COVID-19 and cardiovascular disease: from bench to bedside
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …
consequences on the cardiovascular health of millions of people who survive infection …
Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
Coronavirus Disease 2019 (COVID-19), caused by a new strain of coronavirus called
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), was declared a …
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), was declared a …
SARS-CoV-2 initiates programmed cell death in platelets
M Koupenova, HA Corkrey, O Vitseva… - Circulation …, 2021 - Am Heart Assoc
Rationale: Coronavirus disease 2019 (COVID-19) is characterized by increased incidence
of microthrombosis with hyperactive platelets sporadically containing viral RNA. It is unclear …
of microthrombosis with hyperactive platelets sporadically containing viral RNA. It is unclear …
[HTML][HTML] Extracellular vesicles linking inflammation, cancer and thrombotic risks
S Beck, B Hochreiter, JA Schmid - Frontiers in cell and developmental …, 2022 - frontiersin.org
Extracellular vesicles (EVs) being defined as lipid-bilayer encircled particles are released by
almost all known mammalian cell types and represent a heterogenous set of cell fragments …
almost all known mammalian cell types and represent a heterogenous set of cell fragments …
A post-pandemic enigma: the cardiovascular impact of post-acute sequelae of SARS-CoV-2
COVID-19 has become the first modern-day pandemic of historic proportion, affecting> 600
million individuals worldwide and causing> 6.5 million deaths. While acute infection has had …
million individuals worldwide and causing> 6.5 million deaths. While acute infection has had …
[HTML][HTML] SARS-CoV-2 receptors are expressed on human platelets and the effect of aspirin on clinical outcomes in COVID-19 patients
A Sahai, R Bhandari, M Koupenova… - Research …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease-2019 (COVID-19) caused by SARS-CoV-2 is an ongoing viral
pandemic marked by increased risk of thrombotic events. However, the role of platelets in …
pandemic marked by increased risk of thrombotic events. However, the role of platelets in …
Aspirin in COVID-19: Pros and cons
Since its emergence, the COVID-19 pandemic has been ravaging the medical and
economic sectors even with the significant vaccination advances. In severe presentations …
economic sectors even with the significant vaccination advances. In severe presentations …
Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19
A Sahai, R Bhandari, M Godwin, T McIntyre… - Vascular …, 2021 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is an ongoing viral
pandemic marked by increased risk of thrombotic events. However, the role of platelets in …
pandemic marked by increased risk of thrombotic events. However, the role of platelets in …
Risk of clinically relevant venous thromboembolism in critically ill patients with COVID-19: a systematic review and meta-analysis
J Gratz, M Wiegele, M Maleczek, H Herkner… - Frontiers in …, 2021 - frontiersin.org
Background: Early during the course of the ongoing COVID-19 pandemic, reports suggested
alarmingly high incidences for thromboembolic events in critically ill patients with COVID-19 …
alarmingly high incidences for thromboembolic events in critically ill patients with COVID-19 …
Biomarkers of coagulation and inflammation in COVID-19–associated ischemic stroke
Background and Purpose: We sought to determine if biomarkers of inflammation and
coagulation can help define coronavirus disease 2019 (COVID-19)–associated ischemic …
coagulation can help define coronavirus disease 2019 (COVID-19)–associated ischemic …